Last reviewed · How we verify
NCT06790433
Comparison Between the Dentapen and Vibraject
NA trial testing Vibraject in Pain in 40 participants. Completed in 2 February 2024.
30 December 2023
Quick facts
| Lead sponsor | Riyadh Elm University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 15 October 2023 |
| Primary completion | 30 December 2023 |
| Estimated completion | 2 February 2024 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Vibraject
- Dentapen
Conditions studied
- Pain — all drugs for Pain →
Sponsor
Riyadh Elm University
Who can join
Adults 18 to 65, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A split-mouth, controlled trial aimed to assess patient-reported pain levels during local anaesthesia administration to the buccal side of the maxillary posterior teeth using Vibraject-assisted injection and the Dentapen® system in its ramp-up mode. Pain intensity was evaluated using the Visual Analogue Scale immediately following each injection, and heart rate measurements were recorded before and after each injection. Patient preferences for injection methods were also documented
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06790433
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vibraject
Trials testing the same drug.
- NCT07106138 — Impact of Local Anesthesia Techniques on Children's Dental Treatment Experience · NA · completed
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other Riyadh Elm University trials
Trials by the same sponsor.
- NCT07397871 — Salivary Flow, pH, and Buffering Capacity in Fixed and Clear Aligner Orthodontic Treatment · NA · not yet recruiting
- NCT06503029 — Evaluate Cytotoxicity, Leaching, and Structural Conformation of Clear Aligners · Phase 4 · not yet recruiting
- NCT06161714 — The Effectiveness of Buccal Infiltration Only Using Articaine for Extraction of Mandibular Molar · Phase 4 · unknown
- NCT06093256 — Taste Changes With Fixed Orthodontic Appliances · unknown
- NCT06124742 — Alteration of Taste Among Orthodontic Patients Following Clear Aligners Treatment · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06790433 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Riyadh Elm University
- Last refreshed: 24 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06790433.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing